| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 1.904.163 $ | 99,93 | 351.709 | |||||||
| Sage Therapeutics Inc | Sage Therapeutics Inc | EC | 78667J108 | Long | Börsenkurs (Stufe 1) | 152.527 $ | 8,00 | 3.663 | |
| Biohaven Ltd | Biohaven Ltd | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 136.389 $ | 7,16 | 8.926 | |
| Myriad Genetics Inc | Myriad Genetics Inc | EC | 62855J104 | Long | Börsenkurs (Stufe 1) | 133.802 $ | 7,02 | 7.072 | |
| Intra-Cellular Therapies Inc | Intra-Cellular Therapies Inc | EC | 46116X101 | Long | Börsenkurs (Stufe 1) | 131.744 $ | 6,91 | 2.687 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 127.624 $ | 6,70 | 909 | |
| GH Research PLC | GH Research PLC | EC | IE000GID8VI0 | Long | Börsenkurs (Stufe 1) | 110.266 $ | 5,79 | 11.510 | |
| ACADIA Pharmaceuticals Inc | ACADIA Pharmaceuticals Inc | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 108.416 $ | 5,69 | 5.240 | |
| H Lundbeck A/S | H Lundbeck A/S | EC | DK0061804770 | Long | Börsenkurs (Stufe 1) | 172.536 $ | 9,05 | 42.835 | |
| Alkermes PLC | Alkermes PLC | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 86.584 $ | 4,54 | 3.238 | |
| UCB SA | UCB SA | EC | BE0003739530 | Long | Börsenkurs (Stufe 1) | 85.182 $ | 4,47 | 987 | |
| Sarepta Therapeutics Inc | Sarepta Therapeutics Inc | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 83.659 $ | 4,39 | 685 | |
| Denali Therapeutics Inc | Denali Therapeutics Inc | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 70.156 $ | 3,68 | 2.584 | |
| Biogen Inc | Biogen Inc | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 69.894 $ | 3,67 | 259 | |
| Compass Pathways Plc | Compass Pathways Plc | EC | 20451W101 | Long | Börsenkurs (Stufe 1) | 69.605 $ | 3,65 | 8.437 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 68.149 $ | 3,58 | 661 | |
| Mind Medicine MindMed Inc | Mind Medicine MindMed Inc | EC | 60255C885 | Long | Börsenkurs (Stufe 1) | 55.633 $ | 2,92 | 14.955 | |
| ATAI Life Sciences NV | ATAI Life Sciences NV | EC | NL0015000DX5 | Long | Börsenkurs (Stufe 1) | 46.860 $ | 2,46 | 27.893 | |
| Relmada Therapeutics Inc | Relmada Therapeutics Inc | EC | 75955J402 | Long | Börsenkurs (Stufe 1) | 43.132 $ | 2,26 | 11.981 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 42.606 $ | 2,24 | 278 | |
| Seelos Therapeutics Inc | Seelos Therapeutics Inc | EC | 81577F109 | Long | Börsenkurs (Stufe 1) | 33.699 $ | 1,77 | 42.657 | |
| NRX Pharmaceuticals Inc | NRX Pharmaceuticals Inc | EC | 629444100 | Long | Börsenkurs (Stufe 1) | 27.462 $ | 1,44 | 26.924 | |
| Tonix Pharmaceuticals Holding | Tonix Pharmaceuticals Holding Corp | EC | 890260862 | Long | Börsenkurs (Stufe 1) | 16.206 $ | 0,85 | 23.152 | |
| VistaGen Therapeutics Inc | VistaGen Therapeutics Inc | EC | 92840H202 | Long | Börsenkurs (Stufe 1) | 14.615 $ | 0,77 | 83.230 | |
| Dominari Holdings Inc | Dominari Holdings Inc | EC | 008875304 | Long | Börsenkurs (Stufe 1) | 8.763 $ | 0,46 | 2.213 | |
| Zynerba Pharmaceuticals Inc | Zynerba Pharmaceuticals Inc | EC | 98986X109 | Long | Börsenkurs (Stufe 1) | 8.655 $ | 0,45 | 18.733 | |
| 1.904.163 $ | 99,93 | 351.709 |